key: cord-0959109-0kji9k18
authors: Wang, X.; Pan, Z.; Cheng, Z.
title: Association between 2019-nCoV transmission and N95 respirator use
date: 2020-03-03
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2020.02.021
sha: edf36aa9445285c72e5ef4fbcbc2e8dda92afdea
doc_id: 959109
cord_uid: 0kji9k18

nan

Letter to the editor Association between 2019-nCoV transmission and N95 respirator use

Cases of a novel type of contagious pneumonia were first reported in December 2019 in Wuhan, China. The Centers for Disease Control and Prevention (CDC) and Chinese health authorities have determined that a novel coronavirus (CoV), denoted as 2019-nCoV (SARS-CoV-2), is the cause of this pneumonia outbreak (COVID-19) [1, 2] . Existing evidence has confirmed the human-to-human transmission of 2019-nCoV [3] .

We retrospectively collected infection data from 2 to 22 January 2020 at six departments (Respiratory, Intensive Care Unit (ICU), Infectious Disease, Hepatobiliary Pancreatic Surgery, Trauma and Microsurgery and Urology) from Zhongnan Hospital of Wuhan University. Medical staff (doctors and nurses) followed differential routines of occupational protection: (1) staff at the Departments of Respiratory Medicine, ICU, and Infectious Disease (mainly quarantined area) wore N95 respirators, and disinfected and cleaned their hands frequently (the N95 group); (2) medical staff in the other three departments wore no medical masks, and disinfected and cleaned their hands only occasionally (the no-mask group). The difference was because the latter departments were not considered to be high risk in the early days of the outbreak.

Suspected cases of 2019-nCoV infection were investigated by chest computed tomography, and confirmed by molecular diagnosis. In total, 28 and 58 patients had confirmed and suspected 2019-nCoV-infection, respectively. Patient exposure was significantly higher for the N95 group compared with the no-mask group (for confirmed patients, difference: 733%; exposure odds ratio: 8.33, Table I ).

Among the 493 medical staff, none of the 278 staff (56 doctors and 222 nurses) in the N95 group became infected, but 10 of 213 staff (77 doctors and 136 nurses) from the no-mask group were confirmed as infected ( Table I) . Regardless of their lower risk of exposure, the 2019-nCoV infection rate for medical staff was significantly increased in the no-mask group compared with the N95 respirator group (difference: 4.65%, (95% confidence interval: 1.75%einfinite); P<2.2e-16) (adjusted odds ratio: 464.82, (95% confidence interval: 97.73einfinite); P<2.2e-16).

Likewise, we analysed the medical staff infection data from Huangmei People's Hospital (12 confirmed patients) and Qichun People's Hospital (11 confirmed patients), and observed a similar phenomenon. No medical staff wearing the N95 respirators and following routines of frequent disinfection and hand washing were infected by 2019-nCoV up until 22 January 2020.

A randomized clinical trial has reported that the N95 respirators vs medical masks resulted in no significant difference in the incidence of laboratory confirmed influenza [4] . In our study, we observed that the N95 respirators, disinfection and hand washing appeared to help reduce the infectious risk of 2019-nCoV in doctors and nurses. Interestingly, departments with a high proportion of male doctors seemed to have a higher risk of infection. Our results emphasize the need for strict occupational protection measures in fighting COVID-19.

None declared.

This study was supported by the Medical Science Advancement Program (Clinical Medicine) of Wuhan University (TFLC2018002). Letter to the Editor / Journal of Hospital Infection xxx (xxxx) xxx

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health e The latest 2019 novel coronavirus outbreak in Wuhan, China

Novel coronavirus (2019-nCoV)

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial